0 Комментарии
0 Поделились
114 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
GLP-1 Drug Market – Emerging Indications Beyond Diabetes and ObesityMarket Overview The GLP-1 Drug Market is exploring therapeutic applications far beyond established diabetes and obesity indications, with promising evidence emerging in neurodegenerative diseases, addiction disorders, non-alcoholic steatohepatitis, and polycystic ovary syndrome. The pleiotropic effects of GLP-1 receptor activation on inflammation, neuroprotection, and metabolic regulation...0 Комментарии 0 Поделились 81 Просмотры 0 предпросмотр
-
GLP-1 Drug Market – Oral Therapies Expand Access Beyond Injectable CareOral GLP-1 therapies are emerging as an important opportunity in the GLP-1 drug market. While subcutaneous injections currently dominate with approximately 64% market share, oral formulations are expected to grow quickly as patients seek less invasive and more convenient treatment options.marketresearchfuture Injectable GLP-1 therapies remain central to the market because they have established...0 Комментарии 0 Поделились 117 Просмотры 0 предпросмотр
-
GLP-1 Drug Market - Market Overview and Metabolic Disease Treatment InnovationMarket Overview The GLP-1 drug market is experiencing exponential growth as diabetes prevalence expands dramatically, obesity epidemic intensifies, and advanced GLP-1 agonist formulations enable effective glycemic control, weight loss, and cardiovascular protection for millions of patients requiring metabolic disease management and weight reduction therapy. The GLP-1 Drug Market is...0 Комментарии 0 Поделились 152 Просмотры 0 предпросмотр
-
Short Bowel Syndrome Drugs Market: GLP-2 Analog Pipeline, Parenteral Nutrition Reduction Strategies, and Orphan Drug Development Trends"Market Trends Shaping Executive Summary Short Bowel Syndrome Drugs Market Size and Share Data Bridge Market Research analyses a growth rate in the global short bowel syndrome drugs market in the forecast period 2022-2029. The expected CAGR of global short bowel syndrome drugs market is tend to be around 15% in the mentioned forecast period. The market was valued at USD 1.44 billion in 2021,...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Diabetes Treatments Market Size, Share, and Growth Forecast to 2030According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр